8.15.19
17 min. Read

The AliveCor Report

In this article:

In this 4,400-word report, E&O digs into the strategic moves, challenges and lucky breaks that the AliveCor has team navigated since their original prototype went viral as the breakout device of the Consumer Electronics Show in 2011. How has its most formidable competitor, Apple, forced AliveCor to shift its strategy? What kind of traction does AliveCor have today? What is its path forward? Read on for all this and much, much more.

AliveCor might never have existed if the Speaker of the House during Watergate, Rep. Carl Albert (D-OK) hadn't had heart issues. That inspired his son -- years later -- to pursue biomedical

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!
×

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Approximating Omada Health’s S-1 Before Its 2025 IPO
11.22.24
21 min. Read
The Spring Health Report
8.18.23
20 min. Read
The Sword Health Report
8.02.23
21 min. Read
The Big Health Report
5.12.23
29 min. Read
The Virta Health Report
10.28.22
31 min. Read
Who controls the Spice?
5.27.22
25 min. Read
The Noom Report
10.29.21
39 min. Read
The Crossover Health Report
4.19.21
22 min. Read
Analysis: Livongo founders’ HAAC SPAC
1.25.21
11 min. Read
The UnitedHealth Group Report
12.30.20
30 min. Read
  • First
  • Previous
  • 1 of 2
  • Next
  • Last